Prevention Strategies for Gout
The most effective strategy for preventing gout is a combination of lifestyle modifications and urate-lowering therapy (ULT) for patients with recurrent attacks, tophi, or radiographic changes of gout, with allopurinol as the first-line medication.
Lifestyle Modifications
Dietary Recommendations
Limit or avoid:
Increase consumption of:
Weight Management
- Weight loss is strongly recommended for overweight/obese patients 1, 2
- A weight reduction of 5kg can reduce serum uric acid by approximately 1.1 mg/dL 2
- A BMI reduction of >5% is associated with 40% lower odds of recurrent gout flares 2
- Avoid crash dieting or starvation as these can trigger gout flares 3
Pharmacological Management
Urate-Lowering Therapy (ULT)
ULT is indicated for patients with:
- Recurrent acute attacks
- Arthropathy
- Tophi
- Radiographic changes of gout 1
Allopurinol (First-line ULT)
- Starting dose: 100 mg daily 1, 4
- Titration: Increase by 100 mg every 2-4 weeks until target serum uric acid is reached 1, 4
- Target serum uric acid: <6 mg/dL (360 μmol/L) 1, 2
- For severe gout or tophi: Consider more aggressive target of <5 mg/dL (300 μmol/L) 2
- Dose adjustment for renal impairment: Required 4
- For creatinine clearance 10-20 mL/min: 200 mg daily
- For creatinine clearance <10 mL/min: ≤100 mg daily
Alternative ULT Options
- Uricosuric agents (probenecid, sulphinpyrazone) for patients with normal renal function 1
- Benzbromarone for patients with mild to moderate renal insufficiency (carries small risk of hepatotoxicity) 1
- Febuxostat as an alternative xanthine oxidase inhibitor 2
Flare Prophylaxis When Starting ULT
- Colchicine (0.5-1 mg daily) and/or NSAID with gastroprotection if indicated 1, 5
- Continue prophylaxis for at least 6 months after initiating ULT 2
- For colchicine, FDA-approved dosing should be followed (1.2 mg immediately followed by 0.6 mg an hour later) 1
Special Considerations
Associated Comorbidities
- Address hyperlipidemia, hypertension, hyperglycemia, obesity, and smoking 1
- Consider losartan for hypertension and fenofibrate for hyperlipidemia (both have modest uricosuric effects) 1
- Stop diuretic therapy if possible, as it can raise uric acid levels 1
Monitoring
- Regular monitoring of serum uric acid levels to ensure target is maintained 2
- Monitor renal function, especially in patients with pre-existing kidney disease or on allopurinol 2
- Monitor for flare frequency and tophi size to assess treatment efficacy 2
Common Pitfalls to Avoid
- Not achieving target serum uric acid level (<6 mg/dL) 2
- Suspending ULT during acute attacks (should be continued) 2
- Failing to provide adequate prophylaxis when initiating ULT 2
- Overemphasizing dietary management alone without appropriate pharmacological therapy when indicated 6
- Starting allopurinol at too high a dose, increasing risk of adverse reactions 1, 4
By implementing these comprehensive prevention strategies, patients can significantly reduce their risk of gout flares and complications, improving their overall quality of life and long-term health outcomes.